These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8087861)

  • 1. Effects of zidovudine on B lymphocyte activation.
    Widney D; Yawetz S; van der Meyden M; Miles SA; Kishimoto T; Martínez-Maza O
    Cell Immunol; 1994 Oct; 158(1):140-56. PubMed ID: 8087861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
    Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ
    Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.
    Martínez-Maza O; Crabb E; Mitsuyasu RT; Fahey JL; Giorgi JV
    J Immunol; 1987 Jun; 138(11):3720-4. PubMed ID: 2953790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.
    Macchia D; Almerigogna F; Parronchi P; Ravina A; Maggi E; Romagnani S
    Nature; 1993 Jun; 363(6428):464-6. PubMed ID: 7684824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
    Redgrave BE; Stone SF; French MA; Krueger R; James IR; Price P
    HIV Med; 2005 Sep; 6(5):307-12. PubMed ID: 16156877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell responsiveness to gp120 of human immunodeficiency virus.
    McKallip RJ; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):53-62. PubMed ID: 7878678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV induces IL-6 production by human B lymphocytes. Role of IL-4.
    Boue F; Wallon C; Goujard C; Barre-Sinoussi F; Galanaud P; Delfraissy JF
    J Immunol; 1992 Jun; 148(12):3761-7. PubMed ID: 1376339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
    Feola DJ; Garvy BA; Rapp RP; Thornton AC
    Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.
    Amadori A; Zamarchi R; Ciminale V; Del Mistro A; Siervo S; Alberti A; Colombatti M; Chieco-Bianchi L
    J Immunol; 1989 Oct; 143(7):2146-52. PubMed ID: 2476498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.
    Kersten MJ; Klein MR; Holwerda AM; Miedema F; van Oers MH
    J Clin Invest; 1997 Apr; 99(7):1525-33. PubMed ID: 9119996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6.
    Breen EC; van der Meijden M; Cumberland W; Kishimoto T; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Sep; 92(3):293-9. PubMed ID: 10479534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral treatment induces a shift to type-2 cytokine responses in HIV-1 infected pregnant women.
    Alonso R; Resino S; Bellón JM; Muñoz-Fernández MA
    Eur Cytokine Netw; 2000 Dec; 11(4):647-53. PubMed ID: 11125309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 receptor (CD126'IL-6R') expression is increased on monocytes and B lymphocytes in HIV infection.
    van der Meijden M; Gage J; Breen EC; Taga T; Kishimoto T; Martínez-Maza O
    Cell Immunol; 1998 Dec; 190(2):156-66. PubMed ID: 9878116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
    Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
    J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.